Business · 22/04/1994Updated: 10/15/2026 · 1 min read
Parke-Davis Pharmaceutical Research, et al.; Withdrawal of Approval of 31 Abbreviated New Drug Applications
Summary
The Food and Drug Administration (FDA) is withdrawing approval of 31 abbreviated new drug applications (ANDA's) due to the holders' request to stop marketing the drug products, effective May 23, 1994.
Original source language: Federal Register — Health and Human ServicesOpen original release →